NIA Small Business Funding Opportunities
NIA participates in a broad range of funding opportunities, research and development (R&D) programs, and technical assistance that address innovations in healthy aging as well as Alzheimer’s disease and related dementias (AD/ADRD).
On this page:
This page lists opportunities that are currently open for new submissions, as well as details about a select set of expired announcements. Contact the NIA Small Business Programs team to determine whether your project is a good fit for NIA.
Applications are submitted in response to a notice of funding opportunity (NOFO). The detailed description of each NOFO, including how to submit the award, is outlined at the linked webpage. Unless otherwise indicated in the NOFO, the following funding levels are typically available:
| SBIR NOFOs: | STTR NOFOs: |
|---|---|
| Phase I | Phase I |
| Phase II | Phase II |
| Fast-Track | Fast-Track |
| Direct to Phase II | Phase IIB |
| Phase IIB | n/a |
More on the goal of each funding level can be found on the About NIA Small Business Funding webpage.
Already an awardee? Explore our resources and innovator support programs.
NIA SBIR and STTR Opportunities Targeting AD/ADRD
This type of funding announcement supports investigator-initiated small business research projects focused on developing a variety of AD/ADRD-related innovations.
|
Title |
Links |
Key Details |
|---|---|---|
|
Advancing Research on AD and ADRD Clinical trial optional |
|
NIA SBIR and STTR Omnibus Funding
This funding opportunity supports investigator-initiated small business research projects focused on a broad range of general aging-related innovations that align with NIA’s research priorities. Projects focused on AD may have the best fit in AD-specific opportunities.
|
Title |
Links |
Key Details |
|---|---|---|
|
Current NIH SBIR/STTR Omnibus Solicitation Clinical trial required |
|
|
|
2022 NIH SBIR/STTR Omnibus Solicitation Clinical trial not allowed |
|
More Omnibus Funding Information
NIH Commercialization Readiness Pilot (CRP) Program
This program supports Phase II and Phase IIB awardees seeking additional capital to advance toward commercialization. CRP offers technical assistance to help develop regulatory strategy and submissions to the U.S Food and Drug Administration and other agencies. CRP also supports manufacturing, replication of key studies, compliance activities, and other commercialization readiness research.
|
Title |
Links |
Key Details |
|---|---|---|
|
CRP Technical Assistance Clinical trial not allowed |
|
|
|
CRP Technical Assistance and Late Stage Development Clinical trial not allowed |
|
|
|
CRP Technical Assistance and Late Stage Development Clinical trial required |
|
NIH Special Initiatives and Notices
NIA participates in the following mission-related special initiatives and funding opportunities led by other NIH Institutes, Offices, and Centers. A Notice of Special Interest (NOSI) is written to stimulate grant-supported research in high-priority and high-opportunity areas of science. Investigators planning to submit an application in response to a NOSI are strongly encouraged to contact the NIA program officer listed on the notice.
|
Title |
Links |
Key Details |
|---|---|---|
|
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities Clinical trial optional |
|
|
|
Non-Viral Technologies for In Vivo Delivery of Genome Editors Clinical trial not allowed |
|
|
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management Clinical trial required |
|
|
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management Clinical trial not allowed |
|
|
|
Notice of Special Interest: Small Business Digital Technologies for Early Detection, Characterization and Monitoring of Senescence-Related Changes |
|
|
| Notice of Special Interest: SBIR Technology Transfer
Clinical trial not allowed |
|
NIH Administrative Supplements
Funded awardees can access additional NIA support via administrative supplements.
|
Title |
Links |
Key Details |
|---|---|---|
|
Promoting Diversity in SBIR/STTR Clinical trial not allowed |
|
|
|
Administrative Supplements to Existing NIH Grants and Cooperative Agreements to Address Unexpected Costs Clinical trial optional |
|
Select Expired NIA Funding Opportunities
NIA REDI: Entrepreneurial Development Funding
NIA’s Research and Entrepreneurial Development Immersion (REDI) funding opportunities support entrepreneurial development for early-career scientists working in the fields of aging and aging-related diseases, including AD. Learn more about REDI.
Research and Entrepreneurial Development Immersion (REDI)
REDI funding opportunities support entrepreneurial development for early-career scientists working in the fields of aging and aging-related diseases, including AD, by providing bio-entrepreneurship training that builds additional nonacademic skills for success. Learn more about REDI and view the pre-application webinar recording.
SBIR Contracts Solicitation
NIA began participating in the annual NIH SBIR contracts solicitation in fiscal year 2022. These funding opportunities aim to spur development of specific innovations that address key Institute priorities. Learn more about past NIA SBIR contract topics.
NIA Healthy Aging Start-Up Challenge and Bootcamp to Foster Diversity and Accelerate Innovation
NIA launched this Challenge in spring 2022 to stimulate innovation and foster diversity in aging research and development by providing cash prizes and non-cash prizes that will help participants overcome barriers to participating in life sciences entrepreneurship, particularly for researchers with a demonstrated need who have innovative ideas for science-driven technologies and products. Learn more about the Challenge.
Ready to apply?
- Confirm your eligibility.
- Review tips for applicants.
- Contact the NIA Small Business Programs to discuss fit.
Return to the NIA Small Business Main Page.